Department of Anesthesiology and Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Department of Medicine (Cardiology), UCLA, Los Angeles, California, USA.
Compr Physiol. 2021 Dec 29;12(1):2681-2717. doi: 10.1002/cphy.c200031.
Ca homeostasis is essential for cell function and survival. As such, the cytosolic Ca concentration is tightly controlled by a wide number of specialized Ca handling proteins. One among them is the Na -Ca exchanger (NCX), a ubiquitous plasma membrane transporter that exploits the electrochemical gradient of Na to drive Ca out of the cell, against its concentration gradient. In this critical role, this secondary transporter guides vital physiological processes such as Ca homeostasis, muscle contraction, bone formation, and memory to name a few. Herein, we review the progress made in recent years about the structure of the mammalian NCX and how it relates to function. Particular emphasis will be given to the mammalian cardiac isoform, NCX1.1, due to the extensive studies conducted on this protein. Given the degree of conservation among the eukaryotic exchangers, the information highlighted herein will provide a foundation for our understanding of this transporter family. We will discuss gene structure, alternative splicing, topology, regulatory mechanisms, and NCX's functional role on cardiac physiology. Throughout this article, we will attempt to highlight important milestones in the field and controversial topics where future studies are required. © 2021 American Physiological Society. Compr Physiol 12:1-37, 2021.
钙稳态对于细胞功能和存活至关重要。因此,细胞溶质钙浓度由大量专门的钙处理蛋白严格控制。其中之一是钠-钙交换器(NCX),这是一种普遍存在的质膜转运蛋白,利用钠的电化学梯度将钙驱出细胞,逆浓度梯度进行。在这个关键作用中,这种次级转运蛋白指导着重要的生理过程,如钙稳态、肌肉收缩、骨形成和记忆等。在此,我们回顾了近年来关于哺乳动物 NCX 结构及其与功能关系的研究进展。由于对该蛋白进行了广泛的研究,因此将特别强调哺乳动物心脏同工型 NCX1.1。鉴于真核交换蛋白之间的高度保守性,本文中强调的信息将为我们理解该转运蛋白家族提供基础。我们将讨论基因结构、选择性剪接、拓扑结构、调节机制以及 NCX 在心脏生理学中的功能作用。在整篇文章中,我们将尝试突出该领域的重要里程碑和需要进一步研究的有争议的主题。© 2021 美国生理学会。《综合生理学》12:1-37, 2021。